【August】In a season full of anticipation and hope, the China Blood Safety Conference, hosted by the Chinese Preventive Medicine Association, was successfully held in Nanchang, Jiangxi Province from August 8th to 9th, 2024.

The conference invites numerous industry experts, scholars, as well as biopharmaceutical enterprises and suppliers to participate, aiming to enhance the academic level of blood safety in China, promote exchanges and cooperation in related disciplines and blood products, and ensure the safety of national blood products.

Pual Dong, the General Manager of Wellthinic Technology, has spent many years deeply immersed in the pharmaceutical and blood products industries. With a proven track record of leading and guiding teams through successful digital and intelligent transformations of multiple blood products enterprises, he delivered a speech titled "International Informationization Strategy for Blood Products" at the Global Strategic Theme Conference on Blood Products.

A comprehensive and easy-to-understand analysis of the current overall environment and development trends of informatization in the international pharmaceutical industry, as well as the overall approach to designing a compliant digital factory for blood products.

How to solve the problem of production efficiency of blood products?

The digital platform of Wellthinic Technology adopts an integrated IT/OT solution for the blood products industry. It can not only produce more in the effective plasma with the highest efficiency and better returns, helping enterprises improve quality and efficiency, but also ensure that each batch is a "Golden Batch" under the premise of ensuring compliance.

Communication & Cooperation   Promote Development.

The conference has set up an exhibition and exchange area for enterprises, Through the presentation of various cases, where it showcases the development and innovation of Wellthinic Technology in the digital construction of the blood product industry, intelligent manufacturing, big data analysis, and management systems. It allows more participating experts and scholars, as well as blood product enterprises, to experience the intelligence and efficiency of blood product production.